The effect of neonatal N-methyl-d-aspartate receptor blockade on exploratory and anxiety-like behaviors in adult BALB/c and C57BL/6 mice

Behavioural Brain Research

Volumn 233, Issue 1, 2012, Pages 157-161

  Akillioglu, Kubra ^a   Binokay, Secil ^a   Kocahan, Sayad ^b  

^a CUKUROVA UNIVERSITY   (Turkey)

^b University of Adiyaman   (Turkey)

Author keywords

Anxiety like; BALB C; C57BL 6; Critical period; Exploratory locomotion; NMDA receptor

Indexed keywords

DIZOCILPINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BAGG ALBINO MOUSE; BRAIN DEVELOPMENT; C57BL 6 MOUSE; CONTROLLED STUDY; EXPLORATORY BEHAVIOR; LOCOMOTION; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; RECEPTOR BLOCKING; STRAIN DIFFERENCE;

AGE FACTORS; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; ANXIETY; BODY WEIGHT; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; EXCITATORY AMINO ACID ANTAGONISTS; EXPLORATORY BEHAVIOR; MAZE LEARNING; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; REACTION TIME; RECEPTORS, N-METHYL-D-ASPARTATE; SPECIES SPECIFICITY;

EID: 84861635492     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2012.04.041     Document Type: Article

References (41)

1. Viberg H., Ponten E., Eriksson P., Gordh T., Fredricksson A. Neonatal ketamine exposure results in changes in biochemical substrates of neuronal growth and synaptogenesis, and alters adult behavior irreversibly. Toxicology 2008, 249:153-159.
2. Andersen S.L. Trajectories of brain development: point of vulnerability or window of opportunity?. Neuroscience and Biobehavioral Reviews 2003, 27:3-18.
3. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vöckler J., Dikranian K., et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283:70-74.
4. Ikonomidou C., Bittigau P., Ishimaru M.J., Wozniak D.F., Koch C., Genz K., et al. Ethanol-induced apoptotic neurodegeneration and fetal alcohol syndrome. Science 2000, 287:1056-1060.
5. Pryce C., Mohammed A., Feldon J. Environmental manipulations in rodents and primates: insights into pharmacology, biochemistry and behaviour. Pharmacology Biochemistry and Behavior 2002, 73:1-5.
6. Facchinetti F., Ciani E., Dall'Olio R., Virgili M., Contestabile A., Fonnum F. Structural, neurochemical and behavioral consequences of neonatal blockade of NMDA receptor through chronic treatment with CGP-39551 or MK-801. Developmental Brain Research 1993, 74:219-224.
7. Gorter J.A., de Bruin J.P.C. Chronic neonatal MK-801 treatment results in an impairment of spatial learning in the adult rat. Brain Research 1992, 580:12-17.
8. Gorter J.A., Titulaer M., Bos N.P.A., Huisman E. Chronic neonatal MK-801 administration leads to a long-lasting increase in seizure sensitivity during the early stages of hippocampal kindling. Neuroscience Letters 1991, 134:29-32.
9. Gorter J.A., Botterblom M.H.A., Feenstra M.G.P., Boer G.J. Chronic neonatal NMDA receptor blockade with MK-801 alters monoamine metabolism in the adult rat. Neuroscience Letters 1992, 137:97-100.
10. Griesbach G.S., Amsel A. Immediate and long-term effects of neonatal MK-801 treatment on nonspatial learning. Proceedings of the National Academy of Sciences of the United States of America 1998, 95:11435-11439.
11. Latysheva N.V., Rayevsky K.S. Chronic neonatal N-methyl-d-aspartate receptor blockade induces learning deficits and transient hypoactivity in young rats. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2003, 27:787-794.
12. Nemeth H., Varga H., Farkas T., Kis Z., Vecsei L., Horvath S., et al. Long-term effects of neonatal MK-801 treatment on spatial learning and cortical plasticity in adult rats. Psychopharmacology 2002, 160:1-8.
13. Sircar R. Postnatal phencyclidine-induced deficit in adult water maze performance is associated with N-methyl-d-aspartate receptor upregulation. International Journal of Developmental Neuroscience 2003, 21:159-167.
14. Sircar R., Soliman K.F.A. Effects of postnatal PCP treatment on locomotor behavior and striatal D2 receptor. Pharmacology Biochemistry and Behavior 2003, 74:943-952.
15. Stefani M.R., Moghaddam B. Transient N-methyl-d-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia. Biological Psychiatry 2005, 57:433-436.
16. Haberny K.A., Paule M.G., Scallet A.C., Sistare F.D., Lester D.S., Hanig J.P., et al. Ontogeny of the N-methyl-d-aspartate (NMDA) receptor system and susceptibility to neurotoxicity. Toxicological Sciences 2002, 68:9-17.
17. Lindefors N., Barati S., O'Connor W.T. Differential effects of single and repeated ketamine administration on dopamine, serotonin and GABA transmission in rat medial prefrontal cortex. Brain Research 1997, 759:205-212.
18. Hondo H., Yonezawa Y., Nakahara T., Hirano M., Uchimura H., Tashiro N. Effect of phencyclidine on dopamine release in the prefrontal cortex: an in vivo microdialysis study. Brain Research 1994, 633:337-342.
19. Verma A., Moghaddam B. NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. Journal of Neuroscience 1996, 16:373-379.
20. Löscher W., Hönack D. The behavioural effects of MK-801 in rats: involvement of dopaminergic, serotonergic and noradrenergic systems. European Journal of Pharmacology 1992, 215:199-208.
21. Bourin M., Petit-Demoulière B., Dhonnchadha B.N., Hascöet M. Animal models of anxiety in mice. Fundamental and Clinical Pharmacology 2007, 21:567-574.
22. Carola V., D'Olimpio F., Brunamonti E., Mangia F., Renzi P. Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behavioural Brain Research 2002, 134:49-57.
23. Tang X., Orchard S.M., Sanford L.D. Home cage activity and behavioral performance in inbred and hybrid mice. Behavioural Brain Research 2002, 136:555-569.
24. Lister R.G. The use of a plus-maze to measure anxiety in the mouse. Psycopharmacology 1987, 92:180-185.
25. Benattia C., Albonia S., Montanaria C., Caggia F., Tascedda F., Brunelloa N., et al. Central effects of a local inflammation in three commonly used mouse strains with a different anxious phenotype. Behavioural Brain Research 2011, 224:23-34.
26. Moreira C.M., Mason S., Carvalho M.C., Brandão M.L. Exploratory behaviour of rats in the elevated plus-maze is differentially sensitive to inactivation of the basolateral and central amygdaloid nuclei. Brain Research Bulletin 2007, 71:466-474.
27. An X.L., Zou J.X., Wu R.Y., Yang Y., Tai F.D., Zeng S.Y., et al. Strain and sex differences in anxiety-like and social behaviors in C57BL/6J and BALB/cJ mice. Experimental Animals 2011, 60:11-123.
28. Clément Y., Calatayud F., Belzung C. Genetic basis of anxiety-like behaviour: a critical review. Brain Research Bulletin 2002, 57:57-71.
29. Kinsey S.G., Bailey M.T., Sheridan J.F., Padgett D.A., Avitsur R. Repeated social defeat causes increased anxiety-like behavior and alters splenocyte function in C57BL/6 and CD-1 mice. Brain, Behavior, and Immunity 2007, 21:458-466.
30. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. European Journal of Pharmacology 2003, 463:3-33.
31. Van de Weerd H.A., Van Loo P.L.P., Van Zutphen L.F.M., Koolhaas J.M., Baumans V. Nesting material as environmental enrichment has no adverse effects of behavior and physiology of laboratory mice. Physiology and Behavior 1997, 62:1019-1028.
32. Fredriksson A., Archer T. Neurobehavioural deficits associated with apoptotic neurodegeneration and vulnerability for ADHD. Neurotoxicity Research 2004, 6:435-456.
33. Baier P.C., Blume A., Koch J., Marx A., Fritzer G., Aldenhoff J.B., et al. Early postnatal depletion of NMDA receptor development affects behaviour and NMDA receptor expression until later adulthood in rats a possible model for schizophrenia. Behavioural Brain Research 2009, 205:96-101.
34. Augustsson H., Meyerson B.J. Exploration and risk assessment: a comparative study of male house mice (Mus musculus musculus) and two laboratory strains. Physiology and Behavior 2004, 81:685-698.
35. Crawley J.N., Belknap J.K., Collins A., Crabbe J.C., Frankel W., Henderson N., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology 1997, 132:107-124.
36. Akillioglu K., Melik E.B., Melik E., Boga A. Effect of ketamine on exploratory behaviour in BALB/C and C57BL/6 mice. Pharmacology Biochemistry and Behavior 2012, 100:513-517.
37. Schiffelholz T., Hinze-Selch D., Aldenhoff J.B. Perinatal MK-801 treatment affects age-related changes in locomotor activity from childhood to later adulthood in rats. Neuroscience Letters 2004, 360:157-160.
38. Kawabe K., Iwasaki T., Ichitani Y. Repeated treatment with N-methyl-d-aspartate antagonists in neonatal, but not adult, rats causes long-term deficits of radial-arm maze learning. Brain Research 2007, 1169:77-86.
39. Duncan G.E., Moy S.S., Knapp D.J., Mueller R.A., Breese G.R. Metabolic mapping of the rat brain after subanesthetic doses of ketamine: potential relevance to schizophrenia. Brain Research 1998, 787:181-190.
40. Laprade N., Soghomonian J.J. MK-801 decreases striatal and cortical GAD65 mRNA levels. Neuroreport 1995, 6:1885-1889.
41. Yochuma C.L., Medvecky C.M., Cheh M.A., Bhattacharya P., Wagnera G.C. Differential development of central dopaminergic and serotonergic systems in Balb/c and C57BL/6j mice. Brain Research 2010, 1349:97-104.